HCW Biologics Inc
HCWB9.130USD
-0.919-9.15%
交易中 （美东）报价延迟15分钟
406.66M总市值
亏损市盈率 TTM
关于 HCW Biologics Inc 公司
HCW Biologics Inc. 是一家临床阶段的生物制药公司。该公司专注于发现和开发新型免疫疗法，通过破坏慢性、低度炎症与年龄相关疾病（如癌症、心血管疾病、糖尿病、神经退行性疾病、自身免疫性疾病以及其他疾病，如长期 COVID-19）之间的联系来延长健康寿命。该公司开发了一个基于组织因子的融合 (TOBI) 发现平台，以生成具有免疫治疗特性的设计新型多功能融合分子。其主要候选产品包括 HCW9218 和 HCW9302。HCW9218 是一种双功能免疫治疗药物，具有中和转化生长因子-β 和刺激免疫细胞的能力，靶向衰老细胞及其分泌的 SASP 因子。HCW9302 旨在激活和扩增调节性 T 细胞，从而使炎症小体失活。其其他候选产品包括HCW9201、HCW9206等。
公司简介
公司代码HCWB
公司名称HCW Biologics Inc
上市日期Jul 20, 2021
成立日期2018
CEODr. Hing C. Wong, Ph.D.
员工数量36
证券类型Ordinary Share
年结日Jul 20
公司地址2929 N Commerce Pkwy
城市MIRAMAR
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编33025
电话19548422024
网址https://hcwbiologics.com/
公司代码HCWB
上市日期Jul 20, 2021
成立日期2018
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Hing C. Wong, Ph.D.
Dr. Hing C. Wong, Ph.D.
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
493.86K
+23.05%
Ms. Rebecca Byam
Ms. Rebecca Byam
Chief Financial Officer
Chief Financial Officer
43.01K
+24.49%
Mr. Scott T. Garrett
Mr. Scott T. Garrett
Independent Chairman of the Board
Independent Chairman of the Board
12.08K
+80.41%
Mr. Lee Flowers
Mr. Lee Flowers
Senior Vice President of Business Development
Senior Vice President of Business Development
5.72K
+20.23%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
2.73K
+543.06%
Dr. Peter Rhode, Ph.D.
Dr. Peter Rhode, Ph.D.
Chief Scientific Officer, Vice President of Clinical Operations
Chief Scientific Officer, Vice President of Clinical Operations
1.94K
+0.05%
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
896.00
+0.11%
Mr. Rick S. Greene
Mr. Rick S. Greene
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Hing C. Wong, Ph.D.
Dr. Hing C. Wong, Ph.D.
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
493.86K
+23.05%
Ms. Rebecca Byam
Ms. Rebecca Byam
Chief Financial Officer
Chief Financial Officer
43.01K
+24.49%
Mr. Scott T. Garrett
Mr. Scott T. Garrett
Independent Chairman of the Board
Independent Chairman of the Board
12.08K
+80.41%
Mr. Lee Flowers
Mr. Lee Flowers
Senior Vice President of Business Development
Senior Vice President of Business Development
5.72K
+20.23%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
2.73K
+543.06%
Dr. Peter Rhode, Ph.D.
Dr. Peter Rhode, Ph.D.
Chief Scientific Officer, Vice President of Clinical Operations
Chief Scientific Officer, Vice President of Clinical Operations
1.94K
+0.05%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 18 小时前
更新时间: 18 小时前
持股股东
股东类型
持股股东
股东统计
占比
Wong (Hing C)
43.96%
Armistice Capital LLC
4.50%
Byam (Rebecca)
3.83%
Garrett (Scott T)
1.08%
Avantax Planning Partners, Inc
0.62%
Other
46.01%
持股股东
股东统计
占比
Wong (Hing C)
43.96%
Armistice Capital LLC
4.50%
Byam (Rebecca)
3.83%
Garrett (Scott T)
1.08%
Avantax Planning Partners, Inc
0.62%
Other
46.01%
股东类型
股东统计
占比
Individual Investor
50.05%
Hedge Fund
4.57%
Investment Advisor
1.54%
Investment Advisor/Hedge Fund
1.32%
Research Firm
0.03%
Other
42.48%
机构持股
更新时间: 3月4日 周二
更新时间: 3月4日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q1
37
530.40K
48.29%
+53.17K
2024Q4
37
23.10M
51.86%
+2.14M
2024Q3
33
21.13M
54.31%
+156.07K
2024Q2
33
21.19M
54.45%
+322.27K
2024Q1
34
20.93M
57.88%
+1.69M
2023Q4
33
19.30M
53.71%
+122.06K
2023Q3
33
19.17M
53.35%
-2.58K
2023Q2
33
22.70M
63.26%
-3.42M
2023Q1
32
22.37M
62.46%
-3.36M
2022Q4
32
22.28M
62.20%
-3.33M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Wong (Hing C)
16.05M
35.73%
--
--
Nov 22, 2024
Armistice Capital LLC
2.02M
4.5%
+2.02M
--
Dec 31, 2024
Byam (Rebecca)
1.38M
3.08%
--
--
Apr 15, 2024
Garrett (Scott T)
267.86K
0.6%
+142.86K
+114.29%
Apr 15, 2024
Avantax Planning Partners, Inc
279.54K
0.62%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
37.68K
0.08%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
181.96K
0.4%
-1.30K
-0.71%
Dec 31, 2024
Flowers (Lee)
190.24K
0.42%
+71.43K
+60.12%
Feb 20, 2024
Cresset Asset Management, LLC
131.99K
0.29%
--
--
Dec 31, 2024
查看更多
持股ETF
更新时间: 5月6日 周二
更新时间: 5月6日 周二
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据